DongKook Life Science
KOE: 303810.KQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Jae Won Park
- Employees
- 198
- Headquarters
- Seoul, South Korea
- IPO year
- 2025
- Market cap
- ₩105.5B
- Website
- https://www.dkls.co.kr
Loading 303810…
Loading profile data…Frequently asked questions about 303810
What does DongKook Life Science (303810.KQ) do?
DK Life Science Co., Ltd., a pharmaceutical company, develops and sells diagnostic medicines and medical devices in South Korea, the European Union, Japan, and internationally. It offers active pharmaceutical ingredients (API), injection, blood glucose self-monitoring device, Mobile CT equipment, and ultrasonic instrument. The company was founde...
Where does 303810.KQ trade?
DongKook Life Science (303810.KQ) trades on the KOSDAQ.
What sector is 303810.KQ in?
DongKook Life Science (303810.KQ) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of DongKook Life Science?
Jae Won Park is the chief executive officer of DongKook Life Science (303810.KQ).
Where is DongKook Life Science headquartered?
DongKook Life Science is headquartered in South Korea.
Does 303810.KQ pay a dividend?
DongKook Life Science (303810.KQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 303810.KQ go public?
DongKook Life Science (303810.KQ) completed its initial public offering in 2025.